Company news

CSL Limited news in 2022

CSL Limited's news releases, calls and decks from 2022, newest first.

View company

Appointment of CSLs next CEO & Managing Director

December 12, 2022

CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology

October 31, 2022

CSL Vifor Market Briefing

October 16, 2022

Finalisation of Vifor Pharma Acquisition

August 1, 2022

Vifor update ASX Announcement for lodgement

May 11, 2022

CSL successfully issues bonds in US debt markets

April 20, 2022

Update on Acquisition of Vifor Pharma

March 3, 2022

Statutory Accounts for Half Year Ended 31 December 2021

February 15, 2022

CSL completes A$750 million Share Purchase Plan

February 13, 2022

Decks in 2022